Kawakami Kazuyuki, Minamoto Toshinari
Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
Gan To Kagaku Ryoho. 2010 Nov;37(11):2042-6.
Cancer cells acquire metastatic phenotypes by accumulating genetic and epigenetic abnormalities. DNA methylation is involved in epigenetic regulation of gene transcription and frequently altered with carcinogenesis. Two modes of aberrant DNA methylation, promoter hypermethylation and global hypomethylation, play a role in cancer metastasis with different mechanisms. Here, we discuss how the aberrant DNA methylation contributes to acquisition of metastatic phenotypes in cancer and review the recent trials for molecular diagnosis of cancer metastasis using methylation markers.
癌细胞通过积累遗传和表观遗传异常获得转移表型。DNA甲基化参与基因转录的表观遗传调控,并常随致癌作用而改变。异常DNA甲基化的两种模式,即启动子高甲基化和全基因组低甲基化,通过不同机制在癌症转移中发挥作用。在此,我们讨论异常DNA甲基化如何促进癌症转移表型的获得,并综述最近使用甲基化标记物进行癌症转移分子诊断的试验。